Glioblastoma Multiforme
📧 Sign up to get email alerts when something new happens for Glioblastoma Multiforme.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-04-17Clinical Trial Update: V-Boost Immunotherapy in Glioblastoma Multiforme Brain Cancer [Phase 2]
Phase 2 clinical trial update for V-Boost immunotherapy in glioblastoma multiforme; status and results are currently unknown.
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor) [Phase 2]
Phase 2 trial update for cilengitide in recurrent glioblastoma multiforme.
-
CLINICAL_TRIALS trial_result · 2019-04-12Clinical Trial Update: Hypofractionated Intensity-Modulated Radiation Therapy With Temozolomide and Bevacizumab for Glioblastoma Multiforme [Phase 2]
A Phase 2 clinical trial evaluated hypofractionated IMRT with temozolomide and bevacizumab for glioblastoma multiforme; study status complet…
-
CLINICAL_TRIALS trial_result · 2019-02-18Clinical Trial Update: Impact of [11C]-Methionine PET/MRI for Individual Tailoring Postoperative Radiochemotherapy for Glioblastoma Multiforme
A completed clinical trial evaluating whether [11C]-Methionine PET/MRI can tailor postoperative radiochemotherapy for glioblastoma multiform…
-
FDA approval · 2018-12-05FDA Approved: GLIADEL — Supplemental Application (Azurity Pharmaceuticals, Inc.)
The FDA approved a supplemental application for GLIADEL (carmustine) submitted by Azurity Pharmaceuticals, Inc., resulting in changes to the…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-11-29Clinical Trial Update: Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Grade IV GBM Patients [Phase 2, Phase 3]
Clinical trials investigating chlorogenic acid for injection for safety and efficacy in Grade IV glioblastoma multiforme (GBM) patients, spa…
-
CLINICAL_TRIALS trial_result · 2018-10-29Clinical Trial Update: Temozolomide and SCH66336 for Recurrent Glioblastoma Multiforme [Phase 2]
Phase 2 trial investigating temozolomide with SCH66336 for recurrent glioblastoma multiforme has completed.
-
CLINICAL_TRIALS trial_result · 2018-10-26Clinical Trial Update: Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma [Phase 2]
Phase 2 trial evaluating bevacizumab and erlotinib after radiation and temozolomide in newly diagnosed glioblastoma multiforme or gliosarcom…
-
FDA approval · 2018-10-16FDA Approved: CARMUSTINE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved the original ANDA for Carmustine (BiCNU) submitted by Amneal Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2018-07-31Clinical Trial Update: Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme [Phase 2]
Phase 2 trial evaluating aminolevulinic acid (5-ALA) for fluorescence-guided visualization of glioblastoma tumors during surgical resection …
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: GW572016 to Treat Recurrent Malignant Brain Tumors [Phase 2]
Phase 2 trial of GW572016 (lapatinib) for recurrent malignant brain tumors has completed.
-
CLINICAL_TRIALS trial_result · 2018-07-02Clinical Trial Update: Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating combinations of sorafenib with erlotinib, tipifarnib, or temsirolimus in adults with recurrent glioblastoma multi…
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma Multiforme [Phase 2]
A Phase 2 trial evaluating temozolomide given during and after radiotherapy in patients with newly diagnosed glioblastoma multiforme who had…
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 1]
Phase 1 trial evaluating veliparib (ABT-888) with radiation therapy and temozolomide in newly diagnosed glioblastoma multiforme has complete…
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: Gadolinium Texaphyrin Plus Radiation Therapy in Treating Patients With Supratentorial Glioblastoma Multiforme [Phase 1]
Phase 1 study of gadolinium texaphyrin in combination with radiation therapy for supratentorial glioblastoma multiforme has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-25Clinical Trial Update: Exploratory Study of the Modulation of the Immune System by VEGF Blockade in Patients With Glioblastoma Multiforme (GBM) [EARLY_Phase 1]
An early-phase exploratory trial evaluating immune modulation by VEGF blockade in glioblastoma multiforme; the study has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-21Clinical Trial Update: Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor [Phase 1]
Phase 1 study evaluating Tocagen's retroviral replicating vector Toca 511 in combination with the prodrug 5-fluorocytosine for recurrent mal…
-
CLINICAL_TRIALS trial_result · 2018-05-21Clinical Trial Update: Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor [Phase 1]
This document reports the completion of a Phase 1 trial evaluating a retroviral replicating vector (Toca 511) given intravenously to patient…
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: A Dose-finding Study of Birabresib (MK-8628) in Participants With Recurrent Glioblastoma Multiforme (MK-8628-002) [Phase 2]
Phase 2 dose-finding study of birabresib (MK-8628) in recurrent glioblastoma multiforme was terminated; results were posted.
-
CLINICAL_TRIALS trial_result · 2018-05-15Clinical Trial Update: Immunotoxin Therapy in Treating Children With Progressive or Recurrent Glioblastoma Multiforme or Anaplastic Astrocytoma [Phase 1]
Phase 1 clinical trial evaluating an immunotoxin therapy in children with progressive or recurrent glioblastoma multiforme or anaplastic ast…
-
CLINICAL_TRIALS trial_result · 2018-05-02Clinical Trial Update: A Study Using Allogenic-Cytomegalovirus (CMV) Specific Cells for Glioblastoma Multiforme (GBM) [Phase 1]
A Phase 1 trial evaluating allogeneic CMV-specific cytotoxic T cells for glioblastoma multiforme has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-04-25Clinical Trial Update: Boron Neutron Capture Therapy, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2]
A Phase 2 trial evaluating the combination of boron neutron capture therapy, radiation therapy, and temozolomide for newly diagnosed gliobla…
-
CLINICAL_TRIALS research · 2018-04-10Clinical Trial Update: uPAR-PET/MRI in Glioblastoma Multiforme [Phase 2]
Phase 2 trial evaluating uPAR-PET/MRI in glioblastoma multiforme; the update lists the study status as UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2018-03-30Clinical Trial Update: A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM) in Australia [NA]
This document reports the completion of a feasibility study evaluating the Nativis Voyager System in patients with recurrent glioblastoma mu…
-
CLINICAL_TRIALS trial_result · 2018-01-31Clinical Trial Update: Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme [Phase 1, Phase 2]
A completed phase 1/2 trial evaluating BKM120 (buparlisib) in combination with bevacizumab for relapsed/refractory glioblastoma multiforme a…